NKGen Biotech, Inc. reported that on June 18, 2025, stakeholders approved their Conditional Investment Agreement for acquiring a majority interest in NKMAX, with completion of the acquisition expected in early August 2025.
AI Assistant
NKGEN BIOTECH INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.